High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension
Diana Bonderman(Medical University of Vienna), Iréne Lang(Medical University of Vienna), Christopher Adlbrecht, Peter L. Turecek(University of Vienna), Paul A. Kyrle(Karl Landsteiner Society), Gerald Maurer(European Society of Radiology), Johannes Jakowitsch, Barbara Schneider(Altonaer Kinderkrankenhaus), Meinhard Kneußl, Lewis J. Rubin(University of California San Diego), Ansgar Weltermann, Walter Klepetko(Medical University of Vienna)
Cited by 254
Related Papers
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
|New England Journal of Medicine|2021|2.3k
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
|New England Journal of Medicine|1998|1.7k
Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction
|New England Journal of Medicine|2011|877
High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism
|New England Journal of Medicine|2000|764
PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs
|Journal of Pharmaceutical Sciences|2016|707